Bankrupt Savient Gets OK For $120M Sale To Crealta

A Delaware bankruptcy judge on Friday blessed drug developer Savient Pharmaceuticals Inc.'s sale to Crealta Pharmaceuticals LLC for $120.4 million, more than twice the price initially established by the debtor's stalking horse bidder. ...read more

  • Tags: